УТРЕННИЕ НОВОСТИ

Рыночная стратегия от аналитиков Swissquote

Akzo Nobel to Sell Southeast Asia Decorative Paints Business

Автор: Igor JOVICIC
Oct 5, 2026
Akzo Nobel AKZA has agreed to sell its decorative paints business in Southeast Asia to Nippon Paint 4612 at an enterprise value of $1.35 billion. The Dutch paint company said Monday that net cash proceeds after taxes and minority partners are expected to be about $1 billion.

Nike Plans a Smaller Company as Sales Slide Deepens

Автор: Igor JOVICIC
Oct 2, 2026
Nike NKE is planning to be a smaller company. After two straight quarters of falling revenue, Nike said it expects sales to keep declining this fiscal year and it will shrink its operations, cut jobs and merge regional businesses to adjust. “This work will result in fewer roles across Nike,” Chief Executive Elliott Hill wrote in a memo to employees.

Micron Profit, Revenue Surge as Memory Crunch Looks to Last Through 2028

Автор: Stefano GIANTI
Oct 1, 2026
Micron MU Technology profit and revenue surged in the fiscal fourth quarter, as the company said the shortage of memory chips that has propelled its explosive growth in the past year shows no signs of slowing down. “Industry demand has strengthened since our last earnings call, and we expect memory and storage supply demand conditions to be much tighter in fiscal 2027 and 2028 than they were in 2026,” Chief Executive Sanjay Mehrotra said on a Wednesday call with analysts. Mehrotra’s comments come as investors have debated the durability of the memory shortage that has fueled Micron’s blowout earnings.

Oura Postpones IPO Over Market Uncertainty

Автор: Igor JOVICIC
Sep 30, 2026
Smart-ring maker Oura said it was delaying its previously announced initial public offering due to market uncertainty. The San Francisco-based company, which was expected to fetch a valuation well above the $11 billion achieved in a funding round last year, said Tuesday it was postponing its listing “despite strong demand, due to uncertainty in the IPO market.” Oura made its IPO paperwork public earlier this month. It said the issue had attracted strong investor demand, but that the timing wasn’t right. The company was aiming to list on the Nasdaq as soon as this month.

AMD to Acquire World Labs for $8.2 Billion

Автор: Igor JOVICIC
Sep 29, 2026
Advanced Micro Devices AMD agreed to acquire artificial-intelligence research firm World Labs in an all-stock deal valued at about $8.2 billion, an acquisition that reflects chip makers’ ambitions to control more of the AI stack. AMD, a semiconductor company that recently touched a $1 trillion valuation, said the deal would bring leading AI research and development talent and help the company develop better AI hardware, software and systems, especially in the growing field of physical AI and robotics. World Labs focuses on spatially intelligent AI models that can generate and simulate interactive 3-D environments.

Chemicals Giant BASF Moves for German Rival Evonik

Автор: Stefano GIANTI
Sep 28, 2026
German chemicals producer BASF BAS said it entered initial talks over a takeover of smaller peer Evonik, a tie-up that would bolster BASF’s dominant position in Europe’s chemicals industry.

Anthropic to Pay Akamai Technologies $11.6 Billion for Cloud Services

Автор: Stefano GIANTI
Sep 25, 2026
Anthropic will pay Akamai Technologies AKAM at least $11.6 billion to use its cloud infrastructure and software for over seven years in an expansion of the partnership between the two companies.

OpenAI Agent Hacked Australian Government Website

Автор: Stefano GIANTI
Sep 24, 2026
An OpenAI agent infiltrated a government-services website in Australia this summer, Prime Minister Anthony Albanese said Wednesday at the United Nations meeting in New York.

Meta’s New AI Agent Is an Instant Hit—and the Backlash Has Already Begun

Автор: Stefano GIANTI
Sep 23, 2026
Meta Platforms (-0.6%) appears to have a hit AI product on its hands, but the company’s path to ultimate domination in this next chapter of consumer AI use is anything but assured. Two weeks ago, Meta launched a new, easy-to-use personal AI agent called Muse. The app, which is how users access the agent, has been sitting at No. 1 on Apple’s U.S.

Roche's Eye Drug Susvimo Obtains EU Approval

Автор: Igor JOVICIC
Sep 22, 2026
Roche will be able to market its eye medication Susvimo in the European Union. As the Swiss pharmaceutical company announced, the European Commission has granted approval. Susvimo is a treatment for neovascular age-related macular degeneration.
Switzerland

Разработано с любовью в Швейцарии

Помните о рисках

Торговля на платформе Форекс продуктами с кредитным плечом, такими как валютные пары, спотовые драгоценные металлы и контракты на разницу (CFD), сопряжена со значительным риском потерь из-за кредитного плеча и может подходить не всем инвесторам. Перед открытием счёта в Swissquote оцените свой уровень опыта, инвестиционные цели, активы, доходы и аппетит к риску. Убытки теоретически не ограничены, и вам может потребоваться произвести дополнительные платежи, если баланс вашего счёта упадёт ниже требуемого уровня маржи; поэтому вам не следует использовать для спекуляций, инвестиций или хеджирования капитал, который вы не можете себе позволить потерять, который заимствован, срочно необходим или требуется для личного или семейного обеспечения. За последние 12 месяцев 68.22 % розничных инвесторов либо потеряли деньги при торговле CFD, столкнулись с полной потерей своей маржи при закрытии позиции, либо остались с отрицательным балансом после закрытия позиции. Вы должны быть осведомлены обо всех рисках, связанных с торговлей на рынке Форекс, и обратиться за консультацией к независимому финансовому советнику, если у вас имеются какие-либо сомнения. Для получения более подробной информации, в частности, об эффекте кредитного плеча, принципах работы маржи, а также о контрагентских и рыночных рисках, пожалуйста, ознакомьтесь с нашим Предупреждением о рисках на рынках Форекс и CFD. Контент данного веб-сайта представляет собой рекламный материал. Он не подавался на рассмотрение и не получал одобрения надзорных органов.

Контент, сгенерированный ИИ

Часть визуального контента на нашем веб-сайте была сгенерирована и/или улучшена с использованием приложений искусственного интеллекта (ИИ). При этом весь контент проходит проверку и одобрение человеком для обеспечения его точности, актуальности и соответствия потребностям наших пользователей и клиентов.